摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-decahydro-8-(-pyrrolidinyl)-quinoline | 122832-37-5

中文名称
——
中文别名
——
英文名称
(+/-)-decahydro-8-(-pyrrolidinyl)-quinoline
英文别名
8-pyrrolidin-1-yl-1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline
(+/-)-decahydro-8-(-pyrrolidinyl)-quinoline化学式
CAS
122832-37-5
化学式
C13H24N2
mdl
——
分子量
208.347
InChiKey
SVFRRIUHIIRKFG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    15.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (+/-)-decahydro-8-(-pyrrolidinyl)-quinoline3,4-二氯苯乙酸碳酸氢钠N,N'-羰基二咪唑 作用下, 以 四氢呋喃 为溶剂, 生成 (+/-)decahydro-1-[(3,4-dichlorophenyl)acetyl]-8-(1-pyrrolidinyl) quinoline
    参考文献:
    名称:
    Decahydroquinolines and analgesic use thereof
    摘要:
    该专利描述了十氢喹啉的对映异构体和二对映异构体,化学式为##STR1##其中R.sub.1和R.sub.2分别选择自氢和1到5个碳原子的烷基,或与它们连接的氮原子一起形成一个5到6个成员的杂环,该杂环可以包括另一个杂原子,并且可以选择性地被取代;A从--(CH.sub.2).sub.n--和烷基取代的含有2到8个碳原子的烷基中选择,n是0到5的整数;Z从可选择性地取代的苯基,萘基,茚基,5到6个成员的单环杂环和双环杂环中选择,所有这些都未取代或被一个或多个取代基取代,以及其非毒性、药学上可接受的酸盐和季铵盐,具有中央镇痛作用。
    公开号:
    US04816465A1
  • 作为产物:
    描述:
    8-pyrrolidinyl-5,6,7,8-tetrahydroquinoline 生成 (+/-)-decahydro-8-(-pyrrolidinyl)-quinoline
    参考文献:
    名称:
    CLEMENCE, FRANCOIS;FORTIN, MICHEL;LE, MARTRET ODILE
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • 8-amino decahydroquinolines having central nervous system analgesic
    申请人:Roussel Uclaf
    公开号:US04968700A1
    公开(公告)日:1990-11-06
    Novel enantiomeric and diastereoisomeric forms of decahydroquinolines of the formula ##STR1## wherein R.sub.1 and R.sub.2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms or taken together with the nitrogen atom to which they are connected form a 5 to 6 member heterocycle optionally including another heteroatom and optionally substituted, A is selected from the group consisting of --(CH.sub.2).sub.n -- and alkylene substituted with an alkyl and having 2 to 8 carbon atoms, n is an integer from 0 to 5, Z is selected from the group consisting of optionally substituted phenyl, naphthyl indenyl, monocyclic heterocycle of 5 to 6 members and a bicyclic heterocycle all being unsubstituted or substituted by one or more substituents and their non-toxic, pharmaceuically acceptable acid addition salts and quaternary ammonium salts having central analgesic properties.
    化合物的新对映异构体和顺反异构体,其化学式为##STR1##其中R.sub.1和R.sub.2分别选自氢和1到5个碳原子的烷基的群体,或与它们连接的氮原子共同形成一个5到6个成员的杂环,该杂环可包括另一个杂原子,并可选择性地被取代,A选自--(CH.sub.2).sub.n --和被烷基取代且具有2到8个碳原子的烷基,n为0到5的整数,Z选自可选择性取代的苯基、萘基、茚基、5到6个成员的单环杂环和双环杂环,所有这些均未被取代或被一个或多个取代基取代,以及它们的无毒、药学上可接受的酸盐和季铵盐,具有中枢镇痛作用。
  • Novel hydroquinolines useful as intermediates
    申请人:Roussel Uclaf
    公开号:US04988810A1
    公开(公告)日:1991-01-29
    Novel enantiomeric and diastereoisomeric forms of decahydroquinolines of the formula ##STR1## wherein R.sub.1 and R.sub.2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms or taken together with the nitrogen atom to which they are connected from a 5 to 6 member heterocycle optionally including another heteroatom and optionally substituted, A is selected from the group consisting of --(CH.sub.2).sub.n -- and alkylene substituted with an alkyl and having 2 to 8 carbon atoms, n is an integer from 0 to 5, Z is selected from the group consisting of optionally substituted phenyl, naphthyl indenyl, monocyclic heterocycle of 5 to 6 members and a bicyclic heterocycle all being unsubstituted or substituted by one or more substituents and their non-toxic, pharmaceutically acceptable acid addition salts and quaternary ammonium salts having central analgesic properties.
    该专利描述了一种新的十氢喹啉的对映异构体和顺反异构体,其化学式为 ##STR1## 其中R.sub.1和R.sub.2分别选自氢和1至5个碳原子的烷基的群体,或者与它们连接的氮原子一起形成一个5至6个成员的杂环,该杂环可以包括另一个杂原子,并且可以选择性地被取代,A选自--(CH.sub.2).sub.n --和被烷基取代的烷基,其具有2至8个碳原子,n为0至5的整数,Z选自可选择性取代的苯基、萘基、茚基、5至6个成员的单环杂环和双环杂环,全部未取代或被一个或多个取代基取代,并具有中枢镇痛作用的非毒性、药学上可接受的酸盐和季铵盐。
  • CLEMENCE, FRANCOIS;FORTIN, MICHEL;LE, MARTRET ODILE
    作者:CLEMENCE, FRANCOIS、FORTIN, MICHEL、LE, MARTRET ODILE
    DOI:——
    日期:——
  • US5254566A
    申请人:——
    公开号:US5254566A
    公开(公告)日:1993-10-19
  • Decahydroquinolines and analgesic use thereof
    申请人:Roussel Uclaf
    公开号:US04816465A1
    公开(公告)日:1989-03-28
    Novel enantiomeric and diastereoisomeric forms of decahydroquinolines of the formula ##STR1## wherein R.sub.1 and R.sub.2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms or taken together with the nitrogen atom to which they are connected form a 5 to 6 member heterocycle optionally including another heteroatom and optionally substituted, A is selected from the group consisting of --(CH.sub.2).sub.n -- and alkylene substituted with an alkyl and having 2 to 8 carbon atoms, n is an integer from 0 to 5, Z is selected from the group consisting of optionally substituted phenyl, naphthyl indenyl, monocyclic heterocycle of 5 to 6 members and a bicyclic heterocycle all being unsubstituted or substituted by one or more substituents and their non-toxic, pharmaceutically acceptable acid addition salts and quaternary ammonium salts having central analgesic properties.
    该专利描述了十氢喹啉的对映异构体和二对映异构体,化学式为##STR1##其中R.sub.1和R.sub.2分别选择自氢和1到5个碳原子的烷基,或与它们连接的氮原子一起形成一个5到6个成员的杂环,该杂环可以包括另一个杂原子,并且可以选择性地被取代;A从--(CH.sub.2).sub.n--和烷基取代的含有2到8个碳原子的烷基中选择,n是0到5的整数;Z从可选择性地取代的苯基,萘基,茚基,5到6个成员的单环杂环和双环杂环中选择,所有这些都未取代或被一个或多个取代基取代,以及其非毒性、药学上可接受的酸盐和季铵盐,具有中央镇痛作用。
查看更多

同类化合物

锯齿石松宁 箭毒蛙毒素 C 坎库碘铵 十氢喹啉 十氢-2-甲基喹啉 八氢对苯二酚-4(1H)-酮 八氢喹啉-2(1H)-酮 八氢-2,6-喹啉二酮 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-10a,12a-二甲基-1,2,3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十六氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-1,10a,12a-三甲基-2-氧代-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 8H-13,3,6a-乙基亚基-7,10-亚甲基噁庚并[3,4-i]-1-苯并吖辛因-8-酮,1-乙基十四氢-12a-羟基-6-甲氧基-3-甲基-,(3R,6S,6aS,7R,7aS,10S,12aS,13S,13aR,15R)-(9CI) 8-羟基-十氢喹啉 4-乙炔基-2-甲基十氢喹啉-4-醇 3-羟基-13,17-开环-5-雄甾烯-17-酸-13,17-内酰胺(4-(二(2-氯乙基)氨基)苯基)丁酸酯 2,5-二丙基十氢喹啉 1-(3-氯-丙基)-十氢-喹啉 1,2,2-三甲基-八氢-喹啉-4-酮 (4aS,4bR,8S,10aR,10bS,12aS)-10a,12a-二甲基-2-羰基-1,2,3,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-十六氢萘并[2,1-f]喹啉-8-基{4-[二(2-氯乙基)氨基]苯基}乙酸酯 (4aS,4bR,6aS,8S,10aS,10bS,12aS)-8-羟基-10a,12a-二甲基-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢-1H-萘并[2,1-f]喹啉-2-酮 (3S,13R)-1,2,3,4,4aalpha,5,11,11aalpha-八氢-2,2,5-三甲基-3beta,5beta-乙桥-10bH-吡啶并[3,2-b]咔唑-10bbeta,13-二醇 (3R,6S,6aS,7R,7aS,10S,12aS,13R,13aR,14S,15R)-1-乙基十四氢-12a,14-二羟基-6-甲氧基-3-甲基-8H-13,3,6a-亚乙基-7,10-甲桥氧杂卓并[3,4-i]-1-苯并氮杂环辛四烯-8-酮 (2S,4aR,8aR)-2-甲基八氢-4(1H)-喹啉酮 (2R,4R,4As,8As)-rel-4-乙炔基十氢-1,2-二甲基-4-喹啉醇 (4aS,5R,8aR)-1-(tert-butoxy)carbonyl-2-oxo-5-(triisopropylsilyloxymethyl)decahydroquinoline trans-(+/-)-1-n-propyl-7-oxodecahydroquinoline 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aβH)-benzo[c]quinolizin-3-one 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aαH)-benzo[c]quinolizin-3-one 3,4,4a,5,6,7,8-heptahydro-8a-hydrodioxy-2(1H)-quinolinone [2-(2,3-dichloro-phenyl)-thiazol-4-yl]-(octahydro-quinolin-1-yl)-methanone (octahydro-quinolin-1-yl)-(2-pyridin-3-yl-thiazol-4-yl)-methanone 2-methylperhydrothiazolo<2,3-j>quinoline 2,4-dichloro-N-[5-((4aRS,8aSR)-octahydroquinoline-1-carbonyl)pyridin-2-yl]benzamide (4aR*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-methylquinoline (4aS*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-(methoxycarbonyl)quinoline (2S,3R,4aS,5R,8aR)-1-(tert-butoxy)carbonyl-3-hydroxy-2-methyl-5-(triisopropylsilyloxymethyl)decahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-5-methylene-2-propyldecahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-2-propyldecahydroquinolin-5-one cis-4-[4-(octahydro-quinoline-1(2H)-ylcarbonyl)-thiophen-2-yl]-piperidine-1-carboxylic acid amide lepadin E (+)-lepadin D cis-(octahydro-quinolin-1(2H)-yl)-(5-piperidin-4-yl-thiophen-3-yl)-methanone 4-methyl-6-(3-methyl-2-thienyl)-4,5,6,7-tetrahydroquinolin-5-one 2,2,4,8-tetramethyldecahydroquinoline 10-oxo-2,5;5,9-diseco-A-dinor-strychnidine-2,5-dioic acid strychnidine-2,3,10-trione 3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one 17a-methyl-3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one methyl 4-oxooctahydroquinoline-1(2H)-carboxylate decahydro-2-oxo-8-quinolinepropanoic acid ethyl ester 1-octahydro[1]quinolyl-propan-2-ol